Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
(E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHON, NATRIUMSALZ, ZUR VERWENDUNG IN DER BEHANDLUNG VON SOLIDEN TUMOREN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2023150204
EP Publication Number
4193988
E-Number
1691915
Language
EN
PCT Number
Publication Date
14.06.2023 A
05.06.2024 B1
Registration Date
05.06.2024
AT Publication Date
15.06.2024
Application Date
13.04.2018
Registration Number
-
Priorities
13.04.2017
US
201762485355 P
28.08.2017
US
201715688320
28.08.2017
WO
PCT/US2017/048890
IPC
A61K 9/00 20060101AFI20230425BHEP
Maximum Duration of Protection
13.04.2038
Owner
Onconova Therapeutics, Inc.12 Penns Trail Newtown, PA 18940US
Representative
No representatives present
Inventor
MANIAR, Manoj Fremont, 94539US
see.ip - Details for (E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHON, NATRIUMSALZ, ZUR VERWENDUNG IN DER BEHANDLUNG VON SOLIDEN TUMOREN